Myasthenia Gravis
Showing 376 - 400 of 423
Spinal Muscular Atrophy, Muscular Dystrophy, Muscle Diseases Trial in Cairo
Unknown status
- Spinal Muscular Atrophy
- +4 more
-
Cairo, Abassia, EgyptPediatric Department, Children's Hospital, Faculty of Medicine,
Apr 25, 2014
Refractory Myasthenia Gravis Trial in Syracuse, Burlington (Rituximab (Rituxan))
Completed
- Refractory Myasthenia Gravis
- Rituximab (Rituxan)
-
Syracuse, New York
- +1 more
Jan 15, 2013
Intravenous Glyco-P® in Patients Undergoing Procedure That
Completed
- Hypersalivation
- +3 more
-
Bangkoknoi, Bangkok, ThailandAnesthesiology Department Siriraj Hospital
Apr 2, 2014
Myositis, Myasthenia Gravis Trial in Paris (Rituximab)
Completed
- Myositis
- Myasthenia Gravis
-
Paris, FranceService de Médecine Interne 1 / Groupe Hospitalier Pitié-Salpêtr
Dec 10, 2012
Influenza Trial in Canada, Puerto Rico, United States (High Dose Trivalent Inactivated Influenza Vaccine, Trivalent Inactivated
Completed
- Influenza
- High Dose Trivalent Inactivated Influenza Vaccine
- Trivalent Inactivated Influenza Vaccine
-
Mobile, Alabama
- +112 more
Mar 30, 2015
CHF Trial in Worldwide (Irbesartan, Placebo)
Cardiovascular Diseases, Heart Diseases, CHF Trial in Worldwide (Spironolactone, Placebo)
Completed
- Cardiovascular Diseases
- +2 more
- Spironolactone
- Placebo
-
Birmingham, Alabama
- +269 more
Feb 11, 2015
Type 2 Diabetes Trial in Sapporo-shi (Teneligliptin 20 mg, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Teneligliptin 20 mg
- Placebo
-
Sapporo-shi, Hokkaidou, Japan(unnamed)
Jan 8, 2014
Parkinson's Disease Trial in Princeton (Istradefylline)
Terminated
- Parkinson's Disease
-
Princeton, New JerseyKyowa Pharmaceutical Inc.
Oct 29, 2013
Influenza, Swine-origin A/H1N1 Influenza Trial in United States (Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA),
Completed
- Influenza
- Swine-origin A/H1N1 Influenza
- Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA)
- +3 more
-
Hoover, Alabama
- +14 more
Feb 6, 2014
Type 2 Diabetes Trial in Worldwide (Saxagliptin, Placebo)
Myasthenia Gravis Trial in Chicago (Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF))
Unknown status
- Myasthenia Gravis
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
-
Chicago, IllinoisUniversity of Illinois at Chicago, Department of Neurology
Mar 14, 2012
Atrial Fibrillation Trial in Worldwide (dabigatran dose 1, dabigatran dose 2)
Completed
- Atrial Fibrillation
- dabigatran dose 1
- dabigatran dose 2
-
Birmingham, Alabama
- +566 more
Jun 3, 2014
Labor, Premature Trial in Beirut (Nifedipine)
Terminated
- Labor, Premature
-
Beirut, LebanonAmerican University of Beirut Medical Center
Jul 18, 2013
Acute Decompensated Heart Failure, CHF Trial in Worldwide (Aliskiren, Placebo)
Completed
- Acute Decompensated Heart Failure
- Congestive Heart Failure
- Aliskiren
- Placebo
-
Mobile, Alabama
- +307 more
Oct 15, 2013
Prostatic Tumors Trial in Worldwide (Docetaxel, Leuprolide, Bicalutamide)
Elevated High-sensitivity C-Reactive Protein (hsCRP) Trial in Worldwide (Rosuvastatin, Placebo)
Terminated
- Elevated High-sensitivity C-Reactive Protein (hsCRP)
- Rosuvastatin
- Placebo
-
Birmingham, Alabama
- +858 more
Feb 6, 2014
Atrial Fibrillation, Stroke, Embolism Trial in Worldwide (Rivaroxaban, Warfarin, Matching for Rivaroxaban arm (Warfarin ))
Completed
- Atrial Fibrillation
- +2 more
- Rivaroxaban
- +3 more
-
Birmingham, Alabama
- +958 more
Apr 10, 2014
Incidence and Types of Systemic Reactions Occurring After Spinal Steroid Injection in a Large Population Trial in Seoung Nam
Completed
- Incidence and Types of Systemic Reactions Occurring After Spinal Steroid Injection in a Large Population
- Spinal Steroid Injection
-
Seoung Nam, Bundang, Korea, Republic ofSeoul National University Bundang Hospital
Dec 19, 2012
Parkinson's Disease Trial in Canada, United States (2 mg perampanel, 4 mg perampanel, comparator)
Completed
- Parkinson's Disease
- 2 mg perampanel
- +2 more
-
Birmingham, Alabama
- +113 more
May 13, 2013
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014